Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 43% ± 15% | |
lung | 19 studies | 33% ± 14% | |
brain | 19 studies | 33% ± 18% | |
intestine | 11 studies | 25% ± 8% | |
kidney | 8 studies | 26% ± 7% | |
bone marrow | 5 studies | 43% ± 22% | |
eye | 5 studies | 25% ± 5% | |
adipose | 5 studies | 26% ± 8% | |
lymph node | 5 studies | 33% ± 6% | |
liver | 5 studies | 37% ± 9% | |
heart | 4 studies | 20% ± 1% | |
uterus | 4 studies | 37% ± 13% | |
pancreas | 3 studies | 45% ± 26% | |
placenta | 3 studies | 36% ± 14% | |
breast | 3 studies | 25% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 100% | 6821.34 | 170 / 170 | 100% | 218.25 | 459 / 459 |
esophagus | 100% | 9010.85 | 1444 / 1445 | 100% | 232.42 | 183 / 183 |
breast | 100% | 8865.92 | 459 / 459 | 100% | 287.74 | 1117 / 1118 |
lung | 100% | 10283.12 | 577 / 578 | 100% | 266.52 | 1155 / 1155 |
ovary | 100% | 4869.32 | 180 / 180 | 100% | 136.85 | 429 / 430 |
brain | 99% | 9715.30 | 2627 / 2642 | 100% | 189.88 | 705 / 705 |
bladder | 100% | 7794.43 | 21 / 21 | 99% | 222.42 | 501 / 504 |
stomach | 100% | 6010.56 | 359 / 359 | 99% | 215.12 | 283 / 286 |
intestine | 100% | 9122.20 | 966 / 966 | 99% | 232.21 | 521 / 527 |
thymus | 100% | 6761.22 | 652 / 653 | 99% | 160.69 | 598 / 605 |
prostate | 100% | 6484.74 | 244 / 245 | 99% | 160.80 | 496 / 502 |
skin | 100% | 13629.06 | 1805 / 1809 | 98% | 227.49 | 461 / 472 |
kidney | 100% | 5798.37 | 89 / 89 | 96% | 178.75 | 861 / 901 |
adrenal gland | 100% | 6703.40 | 257 / 258 | 93% | 116.32 | 214 / 230 |
pancreas | 91% | 3436.16 | 299 / 328 | 99% | 210.14 | 176 / 178 |
liver | 97% | 4066.11 | 219 / 226 | 92% | 97.05 | 375 / 406 |
adipose | 100% | 10788.20 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 12248.36 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 429.03 | 29 / 29 |
spleen | 100% | 11002.80 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 213.41 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 71.02 | 1 / 1 |
muscle | 99% | 5325.18 | 797 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 21510.31 | 919 / 929 | 0% | 0 | 0 / 0 |
heart | 93% | 4565.55 | 799 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 109.98 | 72 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0033206 | Biological process | meiotic cytokinesis |
GO_0060271 | Biological process | cilium assembly |
GO_0016344 | Biological process | meiotic chromosome movement towards spindle pole |
GO_0008356 | Biological process | asymmetric cell division |
GO_0007163 | Biological process | establishment or maintenance of cell polarity |
GO_0010592 | Biological process | positive regulation of lamellipodium assembly |
GO_0034314 | Biological process | Arp2/3 complex-mediated actin nucleation |
GO_2001032 | Biological process | regulation of double-strand break repair via nonhomologous end joining |
GO_0051653 | Biological process | spindle localization |
GO_0016482 | Biological process | cytosolic transport |
GO_1905168 | Biological process | positive regulation of double-strand break repair via homologous recombination |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0035578 | Cellular component | azurophil granule lumen |
GO_0005885 | Cellular component | Arp2/3 protein complex |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0030478 | Cellular component | actin cap |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005925 | Cellular component | focal adhesion |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_0005938 | Cellular component | cell cortex |
GO_0005737 | Cellular component | cytoplasm |
GO_0042995 | Cellular component | cell projection |
GO_0035861 | Cellular component | site of double-strand break |
GO_0005634 | Cellular component | nucleus |
GO_0005200 | Molecular function | structural constituent of cytoskeleton |
GO_0051015 | Molecular function | actin filament binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ACTR2 |
Protein name | Actin related protein 2 Actin-related protein 2 (Actin-like protein 2) |
Synonyms | ARP2 |
Description | FUNCTION: ATP-binding component of the Arp2/3 complex, a multiprotein complex that mediates actin polymerization upon stimulation by nucleation-promoting factor (NPF) . The Arp2/3 complex mediates the formation of branched actin networks in the cytoplasm, providing the force for cell motility . Seems to contact the pointed end of the daughter actin filament . In podocytes, required for the formation of lamellipodia downstream of AVIL and PLCE1 regulation . In addition to its role in the cytoplasmic cytoskeleton, the Arp2/3 complex also promotes actin polymerization in the nucleus, thereby regulating gene transcription and repair of damaged DNA . The Arp2/3 complex promotes homologous recombination (HR) repair in response to DNA damage by promoting nuclear actin polymerization, leading to drive motility of double-strand breaks (DSBs) . . |
Accessions | ENST00000260641.10 [P61160-1] A0A1B0GWH0 ENST00000471552.5 ENST00000476840.5 A0A1B0GWD0 Q8IY98 P61160 ENST00000377982.8 [P61160-2] |